Patient Registry Software Market is Expected to Rise at a CAGR of 8.60% during 2023 – 2033

Pune, India, October 2022, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global Patient Registry Software Market.

Market Highlights

The Patient Registry Software Market is expected to reach USD 116.61 Billion by 2032 at 8.60% CAGR during the forecast period 2023 -2032

Patient registry software is an organized system that utilizes observational study methods for collecting clinical as well as non-clinical patient data for evaluation of specified outcomes for a population that is defined by a particular disease, condition, or exposure, and that serves a predetermined clinical, scientific, or policy purposes.

The high adoption rate of electronic health records and increasing use of patient registry data for post-marketing surveillance is anticipated to drive the market growth of the global patient registry software market. However, privacy and data security-related concerns are expected to restrict the market growth.

Segment Analysis

The Global Patient Registry Software Market has been divided based on the type of registry, functionality, deployment model, and end-user. The market, based on type of registry, has been segregated into health service registries, product registries, disease registries, and others. Based on functionality, the patient registry software market has been divided into health information exchange (HIE), population health management (PHM), patient care management, and others. On the basis of deployment model, it is bifurcated into cloud and on-premise cloud. The global patient registry software market, based on end-user, has been categorized as hospitals and clinics, government organizations & research centers and others.

Explore In-depth Market Details [Table of Content, List of Figures, List of Tables] of Patient Registry Software Market Research Report

Regional Analysis

The Global Patient Registry Software Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to hold the largest share of the global patient registry software market during the assessment period. well-established EHRs and development of digital infrastructure in healthcare are likely to support the dominance of the Americas during the forecast period. The Europe market established substantial growth in the market due to the rising government initiatives for the implementation of patient registries in this region. Asia-Pacific is estimated to be the fastest-growing region in the global market due to the reduction of healthcare costs and various initiatives taken by the government for the reduction of the rising pressure to improve the quality of care fueling the growth of the patient registry software market in the region. The patient registry software market in the Middle East & Africa is expected to witness gradual growth due to the increasing awareness about patient registry software.

Market Players

MRFR recognizes the following companies as the Key Players in the Global Patient Registry Software Market— IQVIA(US)., Phamax (Europe), McKesson Corporation (US), Open Text Corporation (Canada), Evado Pty. Ltd(Australia), ArborMetrix(US), IBM(US), Optum, Inc.( US), LUMEDX(US), IFA SYSTEMS(Germany), Dacima Software Inc(Canada) and Others.

Key Findings of the Study

• The Global Patient Registry Software Market is estimated to grow at USD 1,998.83 Million by 2025 at a CAGR of 11.08% during the assessment period.

• The Americas accounted for the largest share of the global market due to the presence of key market players and the development of digital infrastructure in healthcare attributed to the growth of patient registry software in the US and Canada.

• Based on the type of registry, the disease registries segment accounted for the largest market share of 47% in 2018.

• Based on functionality, the population health management (PHM) segment accounted for the largest market share of 41% in 2018.

• Based on the deployment model, the on-premise segment accounted for the largest market share of 56% in 2018.

• On the basis of end-user, the hospitals and clinics segment accounted for the largest market share of 55% in 2018.